Bioniche Life Sciences
Belleville, Canada · Founded 1979
- Headquarters
- Belleville
- Founded
- 1979
- Business Model
- B2B
About
Bioniche has evolved into a research-based, technology-driven Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide. Key areas of strategic focus for Bioniche include developing effective therapies for bladder cancer and potentially other cancers; a cattle vaccine to help prevent E. coli O157:H7 infection; and technologies to improve reproduction and potentially replace the use of antibiotics in livestock.
Summary
Bioniche Life Sciences is a Life Sciences company based in Belleville, Canada, founded in 1979. Investors include BDC Venture Capital.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...